HRT Financial’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.3M | Buy |
+60,803
| New | +$13.3M | 0.06% | 185 |
|
2024
Q4 | – | Sell |
-26,481
| Closed | -$7.95M | – | 3109 |
|
2024
Q3 | $7.95M | Buy |
26,481
+13,966
| +112% | +$4.19M | 0.04% | 266 |
|
2024
Q2 | $4.12M | Buy |
12,515
+4,818
| +63% | +$1.59M | 0.02% | 435 |
|
2024
Q1 | $3.05M | Sell |
7,697
-9,209
| -54% | -$3.64M | 0.02% | 399 |
|
2023
Q4 | $5.95M | Buy |
16,906
+16,031
| +1,832% | +$5.64M | 0.04% | 239 |
|
2023
Q3 | $328K | Buy |
+875
| New | +$328K | ﹤0.01% | 1436 |
|
2023
Q2 | – | Sell |
-38,726
| Closed | -$13.4M | – | 3166 |
|
2023
Q1 | $13.4M | Buy |
38,726
+27,240
| +237% | +$9.44M | 0.16% | 98 |
|
2022
Q4 | $2.7M | Sell |
11,486
-4,282
| -27% | -$1.01M | 0.04% | 440 |
|
2022
Q3 | $3.88M | Buy |
+15,768
| New | +$3.88M | 0.04% | 363 |
|
2022
Q2 | – | Sell |
-8,882
| Closed | -$3.65M | – | 3623 |
|
2022
Q1 | $3.65M | Buy |
+8,882
| New | +$3.65M | 0.03% | 355 |
|
2021
Q3 | – | Sell |
-7,261
| Closed | -$2.61M | – | 3581 |
|
2021
Q2 | $2.61M | Buy |
+7,261
| New | +$2.61M | 0.02% | 487 |
|
2020
Q4 | – | Sell |
-2,549
| Closed | -$700K | – | 2465 |
|
2020
Q3 | $700K | Buy |
+2,549
| New | +$700K | 0.02% | 669 |
|
2020
Q2 | – | Sell |
-3,137
| Closed | -$477K | – | 1643 |
|
2020
Q1 | $477K | Buy |
+3,137
| New | +$477K | 0.03% | 322 |
|
2019
Q4 | – | Sell |
-6,000
| Closed | -$850K | – | 1609 |
|
2019
Q3 | $850K | Buy |
+6,000
| New | +$850K | 0.04% | 360 |
|
2018
Q2 | – | Sell |
-10,600
| Closed | -$935K | – | 362 |
|
2018
Q1 | $935K | Buy |
+10,600
| New | +$935K | 0.45% | 51 |
|